4.6 Article

Improved Genome Packaging Efficiency of Adeno-associated Virus Vectors Using Rep Hybrids

Related references

Note: Only part of the references are listed.
Article Virology

Adeno-associated Virus (AAV) Capsid Chimeras with Enhanced Infectivity Reveal a Core Element in the AAV Genome Critical for both Cell Transduction and Capsid Assembly

Lydia Viney et al.

Summary: Novel AAV-XV variants have been developed for enhanced cell transduction at low doses, indicating the importance of the AAP coding region in both viral particle assembly and cell infection.

JOURNAL OF VIROLOGY (2021)

Article Multidisciplinary Sciences

Adeno-associated virus capsid assembly is divergent and stochastic

Tobias P. Woerner et al.

Summary: Recent research on Adeno-associated viruses (AAVs) using high-resolution native mass spectrometry has revealed that the capsids of different AAV serotypes assemble stochastically, leading to a highly heterogeneous population of capsids with varying compositions. Even the most abundant VP stoichiometry represents only a small percentage of the total AAV population. The systematic scoring of simulations against experimental native MS data offers a sensitive new method to characterize these therapeutically important heterogeneous capsids.

NATURE COMMUNICATIONS (2021)

Review Genetics & Heredity

Engineering adeno-associated virus vectors for gene therapy

Chengwen Li et al.

NATURE REVIEWS GENETICS (2020)

Article Medicine, Research & Experimental

Characterization of AAV-Specific Affinity Ligands: Consequences for Vector Purification and Development Strategies

Mario Mietzsch et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)

Review Clinical Neurology

Current Treatment Options in NeurologySMA Therapeutics

Megan A. Waldrop et al.

CURRENT TREATMENT OPTIONS IN NEUROLOGY (2019)

Review Virology

Twenty-Five Years of Structural Parvovirology

Mario Mietzsch et al.

VIRUSES-BASEL (2019)

Review Biotechnology & Applied Microbiology

The Landscape of Early Clinical Gene Therapies outside of Oncology

Laure Rittie et al.

MOLECULAR THERAPY (2019)

Article Medicine, Research & Experimental

Universal Method for the Purification of Recombinant AAV Vectors of Differing Serotypes

Shelley A. Nass et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)

Review Microbiology

Human Parvoviruses

Jianming Qiu et al.

CLINICAL MICROBIOLOGY REVIEWS (2017)

Article Multidisciplinary Sciences

Structure-guided evolution of antigenically distinct adeno-associated virus variants for immune evasion

Longping Victor Tse et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Medicine, Research & Experimental

Strategies to generate high-titer, high-potency recombinant AAV3 serotype vectors

Chen Ling et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2016)

Article Biochemistry & Molecular Biology

Structural Insights into the Assembly of the Adeno-associated Virus Type 2 Rep68 Protein on the Integration Site AAVS1

Faik N. Musayev et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2015)

Article Medicine, Research & Experimental

Empty virions in AAV8 vector preparations reduce transduction efficiency and may cause total viral particle dose-limiting side effects

Kai Gao et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)

Article Multidisciplinary Sciences

A viral assembly factor promotes AAV2 capsid formation in the nucleolus

Florian Sonntag et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Biochemistry & Molecular Biology

Residues within the B′ motif are critical for DNA binding by the superfamily 3 helicase Rep40 of adeno-associated virus type 2

M Yoon-Robarts et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Biochemistry & Molecular Biology

DNA helicase-mediated packaging of adeno-associated virus type 2 genomes into preformed capsids

JA King et al.

EMBO JOURNAL (2001)